Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions
|ClinicalTrials.gov Identifier: NCT00391300|
Recruitment Status : Unknown
Verified October 2008 by National Cancer Institute (NCI).
Recruitment status was: Active, not recruiting
First Posted : October 23, 2006
Last Update Posted : December 18, 2013
RATIONALE: New diagnostic procedures, such as bioelectric field imaging, may help find and diagnose melanoma and other skin cancers. It may also be a less invasive way to check for skin cancer.
PURPOSE: This phase I trial is studying bioelectric field imaging in diagnosing melanoma and other skin cancers in patients with skin lesions.
|Condition or disease||Intervention/treatment||Phase|
|Melanoma (Skin) Non-melanomatous Skin Cancer||Procedure: bioelectric field imaging Procedure: biopsy Procedure: histopathologic examination||Phase 1|
- To determine if the hand-held Bioelectric Field Imager can be used to measure the electric field in skin of various body surfaces, including face, neck, shoulders, arms, hands, chest, back, legs, and feet, during the course of examination and treatment of patients with suspected malignant skin lesions.
- To determine if there is a significant difference between the lateral electric field strength near benign and malignant skin lesions in the same individual.
OUTLINE: Patients undergo scanning of their skin lesions and nearby healthy skin using the Bioelectric Field Imager (BFI). The lesions are then biopsied for histological diagnosis. Histological data from the biopsy is correlated with the electric field data from the BFI.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Official Title:||Development of an Electrical Diagnostic for Melanoma and Other Cutaneous Malignancies|
|Study Start Date :||October 2006|
|Estimated Primary Completion Date :||April 2007|
|Estimated Study Completion Date :||April 2007|
- Use of Bioelectric Field Imager (BFI) in measuring the electric field in skin of various body surfaces
- Use of BFI in detecting significant electric field differences between malignant and benign skin lesions
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00391300
|United States, Virginia|
|Hampton, Virginia, United States, 23667|
|Principal Investigator:||Antoinette F. Hood, MD||Eastern Virginia Medical School|